United States · Series A startup

Who invested in Oncoceutics

2 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

Undisclosedraised across 2 rounds since 2014, from 2 sources

Latest round
Series AOct 2015
Investors
2
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2015
?Venture?Series A
First round
Venture
Sept 2014
Between rounds
12 months
from the last two

The rounds

  1. Oct 2015
    Series AAmount undisclosed1 returning

    From a historical funding record

  2. Sept 2014
    VentureAmount undisclosed2 new

    From a historical funding record

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Venture2014Series A2015Spring Mountain CapitalRaymond Wong

Everyone who backed them

Spring Mountain CapitalPrivate equity2rounds
Raymond Wongno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Oncoceutics

Who invested in Oncoceutics?

Oncoceutics's investors include Spring Mountain Capital and Raymond Wong.

How much has Oncoceutics raised?

Oncoceutics has raised 2 rounds since 2014, none with a disclosed amount.

When did Oncoceutics last raise?

Oncoceutics's most recent round was a Series A in Oct 2015.

Who backed Oncoceutics first?

Oncoceutics's first round on record, in Sept 2014, was backed by Spring Mountain Capital and Raymond Wong.

What stage is Oncoceutics at?

Oncoceutics's latest named round is a Series A, in Oct 2015.

Where is Oncoceutics based?

Oncoceutics is based in the United States.

Companies like Oncoceutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.